IRLAB Therapeutics AB
STO:IRLAB A

Watchlist Manager
IRLAB Therapeutics AB Logo
IRLAB Therapeutics AB
STO:IRLAB A
Watchlist
Price: 12.6 SEK -1.95% Market Closed
Market Cap: 652.5m SEK
Have any thoughts about
IRLAB Therapeutics AB?
Write Note

Income Statement

Earnings Waterfall
IRLAB Therapeutics AB

Revenue
41.6m SEK
Cost of Revenue
-115.5m SEK
Gross Profit
-73.9m SEK
Operating Expenses
-45.2m SEK
Operating Income
-119.1m SEK
Other Expenses
-330k SEK
Net Income
-119.5m SEK

Income Statement
IRLAB Therapeutics AB

Rotate your device to view
Income Statement
Currency: SEK
Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024
Revenue
Revenue
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
196
N/A
208
+6%
217
+4%
240
+11%
61
-75%
61
+0%
52
-15%
36
-32%
19
-46%
6
-70%
6
N/A
42
+632%
Gross Profit
Cost of Revenue
0
0
0
0
(66)
0
0
0
(82)
0
0
0
(126)
(68)
(106)
(136)
(128)
(117)
(115)
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
(66)
N/A
0
N/A
0
N/A
0
N/A
126
N/A
0
N/A
0
N/A
0
N/A
(65)
N/A
(55)
+14%
(87)
-58%
(117)
-34%
(123)
-5%
(111)
+10%
(74)
+33%
Operating Income
Operating Expenses
(96)
(97)
(93)
(98)
(26)
(92)
(93)
(140)
(73)
(173)
(197)
(164)
(48)
(128)
(91)
(61)
(58)
(48)
(45)
Selling, General & Administrative
(22)
(23)
(23)
(23)
(24)
(24)
(24)
(27)
(31)
(35)
(37)
(39)
(42)
(54)
(55)
(55)
(53)
(43)
(45)
Research & Development
0
0
0
0
0
0
0
(39)
(39)
0
(39)
0
0
0
0
0
0
0
0
Depreciation & Amortization
(3)
(3)
(3)
(3)
(2)
(2)
(3)
(3)
(3)
(4)
(4)
(4)
(5)
(5)
(5)
(5)
(4)
(4)
(4)
Other Operating Expenses
(71)
(71)
(67)
(72)
0
(66)
(66)
(70)
0
(135)
(117)
(120)
(1)
(69)
(30)
(1)
(1)
(1)
4
Operating Income
(96)
N/A
(97)
-1%
(93)
+4%
(98)
-6%
(91)
+7%
(92)
-1%
(93)
0%
56
N/A
53
-6%
43
-17%
43
-1%
(103)
N/A
(113)
-10%
(144)
-27%
(161)
-12%
(178)
-10%
(181)
-1%
(159)
+12%
(119)
+25%
Pre-Tax Income
Interest Income Expense
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(1)
(1)
(1)
(1)
(0)
(0)
(0)
2
3
2
(0)
Total Other Income
0
0
0
0
0
0
0
0
0
(0)
0
0
0
0
0
0
0
0
0
Pre-Tax Income
(96)
N/A
(98)
-1%
(93)
+4%
(99)
-6%
(92)
+7%
(93)
-1%
(93)
-1%
55
N/A
52
-7%
43
-18%
42
-1%
(103)
N/A
(113)
-10%
(144)
-27%
(162)
-12%
(176)
-9%
(178)
-1%
(157)
+12%
(119)
+24%
Net Income
Tax Provision
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Income from Continuing Operations
(96)
(98)
(93)
(99)
(92)
(93)
(93)
55
52
43
42
(103)
(113)
(144)
(162)
(176)
(178)
(157)
(119)
Net Income (Common)
(96)
N/A
(98)
-1%
(93)
+4%
(99)
-6%
(92)
+7%
(93)
-1%
(93)
-1%
55
N/A
52
-7%
43
-18%
42
-1%
(103)
N/A
(113)
-10%
(144)
-27%
(162)
-12%
(176)
-9%
(178)
-1%
(157)
+12%
(119)
+24%
EPS (Diluted)
-2.33
N/A
-2.16
+7%
-1.92
+11%
-2.03
-6%
-1.92
+5%
-1.78
+7%
-1.79
-1%
1.07
N/A
1
-7%
0.82
-18%
0.81
-1%
-2
N/A
-2.19
-10%
-2.77
-26%
-3.11
-12%
-3.39
-9%
-3.43
-1%
-3.03
+12%
-2.3
+24%

See Also

Discover More